Come up with a name for your new list and we'll add to it:
GlyCardial Diagnostics raised a round of funding on August 09, 2018. Investors include
European Institute of Innovation and Technology.
GlyCardial Diagnostics is developing Apo J-Glyc as a biomarker for the diagnosis and prognosis of myocardial ischemia.…